NephTech

NephTech, founded in Singapore in 2015, operated in the medical technology sector with a focus on vascular health for dialysis patients. The company was established by Lim Soo Ghim, Toh Yanling, and Dr. James Lim. The founding team's background was rooted in the MedTech R&D space and the Singapore-Stanford Biodesign (SSB) Programme, with Dr. Lim, a biomaterials scientist, having prior experience in a kidney-related A*STAR spin-off, and Toh Yanling providing expertise in medical device regulatory affairs. This experience led them to identify a significant unmet need for better vascular access surveillance during a previous dialysis-related project.

The company's primary offering was a non-invasive, portable measurement tool designed for vascular access surveillance. This device targeted both dialysis centers and home-based hemodialysis patients, aiming to provide an evidence-based approach to managing a patient's vascular access, which is crucial for the hemodialysis process. The technology integrated sensors, signal algorithms, and cloud computing to predict the development of stenotic events—a common complication involving the narrowing of blood vessels. By enabling early detection of potential blockages, the product intended to simplify how clinicians assess complications, thereby potentially reducing hospitalizations and associated costs for patients with end-stage kidney failure.

NephTech's business model focused on providing this monitoring solution to healthcare providers. The company engaged directly with dialysis center owners and clinicians to ensure the product integrated with existing workflows. Over its active years, NephTech secured approximately $886K in total funding through various rounds, including grants, equity crowdfunding, and seed rounds, with investors such as Safron Company, She1K, NTUitive, and FundedHere. The company was also a participant in the NTU-NUS JUMPstart accelerator program. However, according to market data, NephTech is no longer in business as of early 2022.

Keywords: vascular access surveillance, hemodialysis monitoring, renal care technology, dialysis complications, non-invasive diagnostics, stenosis prediction, MedTech Singapore, kidney disease management, vascular health, home hemodialysis, clinical decision support, medical sensor technology, signal algorithm, cloud-based health monitoring, end-stage renal disease, preventative care, digital health, patient monitoring systems, vascular patency, dialysis access management